Catalyst Wire Dossier Catalyst Wire Dossier

Lucerastat

lucerastat · Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Lucerastat, covering 2018-07-10 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease [Phase 3]

See pricing